This topic contains a solution. Click here to go to the answer

Author Question: Which entry mode below presents the lowest risk? a. Licensing, c. Franchising b. Indirect exporting ... (Read 89 times)

fbq8i

  • Hero Member
  • *****
  • Posts: 527
Which entry mode below presents the lowest risk?
 a. Licensing, c. Franchising
  b. Indirect exporting d. Wholly-owned subsidiary

Question 2

Free monitoring tools are useful for:
 A) calculating customer satisfaction KPI formulas.
  B) qualitative measurements.
  C) observing what people are saying about a brand.
  D) evaluating the effectiveness of social media tactics.
  E) measuring branding efforts.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

aham8f

  • Sr. Member
  • ****
  • Posts: 336
Answer to Question 1

B
The entry mode classification that follows a general model of low to high control and risk is: indirect exporting, direct exporting, licensing, franchising, joint ventures, branch offices, wholly-owned subsidiaries. This may be found in the Deciding on the International Entry Mode section (8-3).

Answer to Question 2

C




fbq8i

  • Member
  • Posts: 527
Reply 2 on: Jun 29, 2018
YES! Correct, THANKS for helping me on my review


kusterl

  • Member
  • Posts: 315
Reply 3 on: Yesterday
:D TYSM

 

Did you know?

About 60% of newborn infants in the United States are jaundiced; that is, they look yellow. Kernicterus is a form of brain damage caused by excessive jaundice. When babies begin to be affected by excessive jaundice and begin to have brain damage, they become excessively lethargic.

Did you know?

Elderly adults are at greatest risk of stroke and myocardial infarction and have the most to gain from prophylaxis. Patients ages 60 to 80 years with blood pressures above 160/90 mm Hg should benefit from antihypertensive treatment.

Did you know?

Medication errors are more common among seriously ill patients than with those with minor conditions.

Did you know?

For pediatric patients, intravenous fluids are the most commonly cited products involved in medication errors that are reported to the USP.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library